• Price-Driven Insight from (RYTM) for Rule-Based Strategy Stock Traders Daily Thu, 09 Jul 2026 19:58:01 GMT
• Enterprise value to revenue forward of Rhythm Pharmaceuticals, Inc. – XETR:1RV TradingView Thu, 09 Jul 2026 16:19:57 GMT
• Rhythm Pharmaceuticals (RYTM) On TRANSCEND And New Approvals, Buying Opportunity Or Priced In? simplywall.st Thu, 09 Jul 2026 15:44:30 GMT
• Rhythm Pharmaceuticals Inc. announced that the results of its Phase 3 Transcend clinical trial for acquired hypothalamic obesity h... Bitget Thu, 09 Jul 2026 01:48:32 GMT
• Rhythm Pharmaceuticals Announces The New England Journal of GlobeNewswire Wed, 08 Jul 2026 21:07:01 GMT
• rytm maintained by rbc capital -- price target raised to $141.00 GuruFocus Tue, 07 Jul 2026 17:36:41 GMT
• RBC Capital Adjusts Rhythm Pharmaceuticals Price Target to $141 From $137, Maintains Outperform Rating Moomoo Tue, 07 Jul 2026 12:17:45 GMT
• Rhythm Pharmaceuticals, Inc. (RYTM) Stock Analysis: A Biotech Contender with 22% Upside Potential DirectorsTalk Interviews Mon, 06 Jul 2026 09:23:53 GMT
• Price to sales forward of Rhythm Pharmaceuticals, Inc. – NASDAQ:RYTM TradingView Sun, 05 Jul 2026 12:53:20 GMT
• rhythm pharmaceuticals announces public offering of common stock MSN Sat, 04 Jul 2026 00:49:24 GMT
• Rhythm Pharmaceuticals Inc to Discuss Interim Six-Month Phase 2 Results Evaluating Setmelanotide Call Transcript GuruFocus Fri, 03 Jul 2026 20:32:09 GMT
• Rhythm Pharmaceuticals (RYTM) CSO exercises RSUs, 2,150 shares withheld for taxes Stock Titan Thu, 02 Jul 2026 20:53:28 GMT
• Rhythm Pharmaceuticals (RYTM) Could Be 21% Undervalued As Trial Data Strengthens Its Case simplywall.st Thu, 02 Jul 2026 06:42:31 GMT
• medicare coverage could put these obesity drug stocks in focus simplywall.st Tue, 30 Jun 2026 15:52:58 GMT
• Rhythm Pharmaceuticals Stock Surges 28%, With A 12-Day Winning Spree Trefis Tue, 30 Jun 2026 13:53:39 GMT
• Rhythm Pharmaceuticals Stock On Fire: Up 28% With 12-Day Winning Streak Trefis Tue, 30 Jun 2026 13:21:48 GMT
• Is Rhythm Pharmaceuticals, Inc. (RYTM) Stock Poised for Growth After Encouraging Setmelanotide Trial Results? Yahoo Finance Tue, 30 Jun 2026 07:00:00 GMT
• Rhythm Pharmaceuticals, Inc. (RYTM) Stock Analysis: A Biotech with Promising Upside and Strong Buy Ratings DirectorsTalk Interviews Mon, 29 Jun 2026 09:24:20 GMT
• (rytm) price dynamics and execution-aware positioning Stock Traders Daily Sun, 28 Jun 2026 18:50:01 GMT
• rhythm pharmaceuticals highlights obesity pipeline, shares track sector peers Ad-hoc-news.de Fri, 26 Jun 2026 20:03:54 GMT
• rhythm pharmaceuticals stock on fire: up 26% with 10-day winning streak Trefis Fri, 26 Jun 2026 10:23:34 GMT
• rhythm pharmaceuticals 8-k filing june 2026 – company details, nasdaq listing, and executive information Minichart Fri, 26 Jun 2026 02:38:00 GMT
• Form 4 Rhythm Pharmaceuticals Inc For: 25 June By Investing.com Investing.com Nigeria Fri, 26 Jun 2026 01:13:38 GMT
• form 4 rhythm pharmaceuticals inc for: 25 june by investing.com Investing.com Canada Thu, 25 Jun 2026 22:20:47 GMT
• rhythm pharmaceuticals, inc. actuals & estimates (nasdaq:rytm) TradingView Thu, 25 Jun 2026 14:09:31 GMT
• [Form 4] RHYTHM PHARMACEUTICALS, INC. Insider Trading Activity Stock Titan Thu, 25 Jun 2026 07:00:00 GMT
• Rhythm Pharmaceuticals on Track for Highest Close Since January -- Data Talk Moomoo Thu, 25 Jun 2026 07:00:00 GMT
• Director at Rhythm Pharmaceuticals (RYTM) receives new RSUs, options and exercises units Stock Titan Thu, 25 Jun 2026 07:00:00 GMT
• Rhythm Pharmaceuticals (RYTM) director receives RSUs, options and converts 4,712 RSUs Stock Titan Thu, 25 Jun 2026 07:00:00 GMT
• Rhythm Pharmaceuticals (RYTM) director granted RSUs, options and new shares Stock Titan Thu, 25 Jun 2026 07:00:00 GMT
• Rhythm Pharmaceuticals (NASDAQ: RYTM) holders approve directors, pay and Ernst & Young Stock Titan Thu, 25 Jun 2026 07:00:00 GMT
• Rhythm Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director JEAN CHRISTOPHE Moomoo Thu, 25 Jun 2026 07:00:00 GMT
• rhythm pharmaceuticals inc (rytm) earnings forecast: future eps & revenue growth estimates TradingKey Thu, 25 Jun 2026 07:00:00 GMT
• rhythm pharmaceuticals | 4: statement of changes in beneficial ownership of securities-director tetrault lynn a. Moomoo Wed, 24 Jun 2026 20:16:40 GMT
• Rhythm Pharmaceuticals(RYTM.US) Director Sells US$3.71 Million in Common Stock Moomoo Wed, 24 Jun 2026 07:00:00 GMT
• Rhythm Pharmaceuticals (RYTM) Is Up 7.9% After Promising Early PWS Data for Setmelanotide - What's Changed simplywall.st Wed, 24 Jun 2026 07:00:00 GMT
• Rhythm Pharmaceuticals (RYTM) director exercises options and sells 37,000 shares Stock Titan Wed, 24 Jun 2026 07:00:00 GMT
• rhythm pharmaceuticals (rytm) stock could be 30.6% undervalued on its growth narrative Sahm Tue, 23 Jun 2026 07:56:07 GMT
• form 144 rhythm pharmaceuticals for: 22 june by investing.com Investing.com Nigeria Mon, 22 Jun 2026 22:51:08 GMT
• form 144 | rhythm pharmaceuticals(rytm.us) director proposes to sell 3.58 million in common stocks Moomoo Mon, 22 Jun 2026 20:50:39 GMT
• Can Rhythm Pharmaceuticals (RYTM) ’s New Data Help Patients With a Rare Hunger Disorder? Yahoo Finance Mon, 22 Jun 2026 07:00:00 GMT
• Rhythm Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144 Moomoo Mon, 22 Jun 2026 07:00:00 GMT
• rhythm pharmaceuticals (rytm) stock could be 30.6% undervalued on its growth narrative simplywall.st Mon, 22 Jun 2026 07:00:00 GMT
• rhythm pharmaceuticals inc (rytm) institutional confidence TradingKey Mon, 22 Jun 2026 07:00:00 GMT
• rhythm pharmaceuticals inc (rytm) earnings forecast: future eps & revenue growth estimates TradingKey Sun, 21 Jun 2026 07:00:00 GMT
• rhythm pharmaceuticals inc (rytm) dividends & stock splits: historical payouts and event timeline TradingKey Fri, 19 Jun 2026 09:15:28 GMT
• rhythm pharmaceuticals inc (rytm) shareholder structure: major shareholders & institutional holdings TradingKey Fri, 19 Jun 2026 05:59:24 GMT
• palatin technologies is pursuing the next generation of mc4r. rhythm just reinforced why that matters Benzinga Wed, 17 Jun 2026 18:22:40 GMT
• rhythm pharmaceuticals inc (rytm) institutional confidence TradingKey Wed, 17 Jun 2026 17:43:56 GMT
• (rytm) as a liquidity pulse for institutional tactics Stock Traders Daily Wed, 17 Jun 2026 17:38:02 GMT
• rhythm pharmaceuticals inc (rytm) valuation: pe, pb & fair value analysis TradingKey Wed, 17 Jun 2026 16:04:49 GMT
• rhythm pharmaceuticals inc (rytm) technical analysis: support, resistance, indicators & moving averages TradingKey Wed, 17 Jun 2026 14:55:54 GMT
• rhythm pharmaceuticals inc (rytm) earnings forecast: future eps & revenue growth estimates TradingKey Wed, 17 Jun 2026 14:55:42 GMT
• TD Cowen Maintains Rhythm Pharmaceuticals(RYTM.US) With Buy Rating, Maintains Target Price $130 Moomoo Wed, 17 Jun 2026 07:00:00 GMT
• rhythm pharmaceuticals stock price target reiterated at $130 by td cowen Investing.com Wed, 17 Jun 2026 07:00:00 GMT
• rhythm pharmaceuticals, inc. (rytm) discusses positive interim results from phase 2 setmelanotide trial in prader-willi syndrome -... Seeking Alpha Wed, 17 Jun 2026 07:00:00 GMT
• ccorf maintains rhythm pharmaceuticals(rytm.us) with buy rating, raises target price to $151 Moomoo Tue, 16 Jun 2026 13:31:00 GMT
• Rhythm Pharmaceuticals posts long-term setmelanotide data for obesity Proactive financial news Tue, 16 Jun 2026 07:00:00 GMT
• Canaccord raises Rhythm Pharmaceuticals price target on trial data Investing.com Tue, 16 Jun 2026 07:00:00 GMT
• Citizens reiterates Rhythm Pharmaceuticals stock rating on bivamelagon data Investing.com Tue, 16 Jun 2026 07:00:00 GMT
• a quick look at today's ratings for rhythm pharmaceuticals(rytm.us), with a forecast between $105 to $155 Moomoo Tue, 16 Jun 2026 07:00:00 GMT
• how new prader‑willi phase 2 setmelanotide data at rhythm pharmaceuticals (rytm) has changed its investment story simplywall.st Tue, 16 Jun 2026 07:00:00 GMT
• stifel reiterates rhythm pharmaceuticals stock rating on pws data by investing.com Investing.com Australia Tue, 16 Jun 2026 07:00:00 GMT
• rhythm pharmaceuticals inc (rytm) technical analysis: support, resistance, indicators & moving averages TradingKey Tue, 16 Jun 2026 07:00:00 GMT
• rhythm presents data on obesity treatments at endocrine meeting by investing.com Investing.com South Africa Tue, 16 Jun 2026 03:20:53 GMT
• rhythm pharma shares rise after positive 6-mont... | pluang – crypto, stocks, gold & funds Pluang Mon, 15 Jun 2026 17:27:17 GMT
• rhythm pharmaceuticals, inc. (rytm) stock analysis: promising upside amidst strong buy ratings DirectorsTalk Interviews Mon, 15 Jun 2026 09:23:51 GMT
• How This Biotech Is Taking On Genetic Obesity — And Winning Investor's Business Daily Mon, 15 Jun 2026 07:00:00 GMT
• Rhythm’s obesity drug scores ‘better than expected’ weight loss in rare genetic disease BioSpace Mon, 15 Jun 2026 07:00:00 GMT
• Why Is Rhythm Pharma Stock Jumping Today? - Rhythm Pharmaceuticals (NASDAQ:RYTM) Benzinga Mon, 15 Jun 2026 07:00:00 GMT
• Rhythm trial finds up to 38% BMI drop in complex rare obesity cases Stock Titan Mon, 15 Jun 2026 07:00:00 GMT
• rhythm pharmaceuticals announces multiple new data presentations from mc4r agonists in acquired hypothalamic obesity (ho), bardet-... GlobeNewswire Mon, 15 Jun 2026 07:00:00 GMT
• stifel reiterates rhythm pharmaceuticals stock rating on pws data Investing.com Mon, 15 Jun 2026 07:00:00 GMT
• rhythm pharmaceuticals (rytm) reports strong mc4r obesity data across pws, ho and bbs at endo 2026 Stock Titan Mon, 15 Jun 2026 07:00:00 GMT
• rhythm pharmaceuticals inc (rytm) earnings forecast: future eps & revenue growth estimates TradingKey Mon, 15 Jun 2026 07:00:00 GMT
• rhythm pharmaceuticals (rytm) announces positive phase 2 trial r GuruFocus Mon, 15 Jun 2026 00:37:09 GMT
• rhythm pharmaceuticals (rytm) stock after positive phase 2 pws data what does the valuation suggest simplywall.st Sun, 14 Jun 2026 18:17:12 GMT
• Rhythm Pharmaceuticals Presents Positive Interim Six-month Data from Phase 2 Trial of Setmelanotide in Patients with Prader-Willi ... GlobeNewswire Sat, 13 Jun 2026 07:00:00 GMT
• Rhythm Pharmaceuticals reports phase 2 PWS trial results Investing.com Sat, 13 Jun 2026 07:00:00 GMT
• Rhythm Pharmaceuticals Says Six-Month Data Shows Setmelanotide Improves Multiple Endpoints In Pws TradingView Sat, 13 Jun 2026 07:00:00 GMT
• experimental pws drug cuts body fat and hunger in small six-month trial Stock Titan Sat, 13 Jun 2026 07:00:00 GMT
• rhythm pharmaceuticals to announce interim six-month phase 2 results evaluating setmelanotide in patients with prader-willi syndro... The Manila Times Sat, 13 Jun 2026 07:00:00 GMT
• rhythm pharmaceuticals reports positive phase 2 results for pws treatment Intellectia AI Sat, 13 Jun 2026 00:07:31 GMT
• rhythm pharmaceuticals to announce interim six-month phase 2 results evaluating setmelanotide in patients with prader-willi syndro... Yahoo Finance Singapore Fri, 12 Jun 2026 20:01:00 GMT
• Rhythm Pharmaceuticals to Host Conference Call on Phase 2 Trial Results for Setmelanotide in Prader-Willi Syndrome Quiver Quantitative Fri, 12 Jun 2026 07:00:00 GMT
• Prader-Willi syndrome trial update slated for June 13 webcast Stock Titan Fri, 12 Jun 2026 07:00:00 GMT
• rhythm pharmaceuticals, inc. (rytm) reports q1 loss, tops revenue estimates MSN Thu, 11 Jun 2026 23:17:56 GMT
• rytm: endo to feature key praloretel and rm-718 data as ho launch gains momentum in rare disease space TradingView Mon, 08 Jun 2026 18:46:36 GMT
• rhythm pharmaceuticals, inc. (rytm) stock analysis: exploring a 59.95% potential upside in the biotech sector DirectorsTalk Interviews Mon, 08 Jun 2026 07:00:00 GMT
• long term debt to total assets ratio of rhythm pharmaceuticals, inc. – xetr:1rv TradingView Mon, 08 Jun 2026 06:51:48 GMT
• how investors may respond to rhythm pharmaceuticals (rytm) updating its bardet-biedl diagnosis algorithm Yahoo Finance Mon, 08 Jun 2026 02:10:00 GMT
• did rhythm’s new bardet-biedl diagnostic algorithm just shift rhythm pharmaceuticals' (rytm) investment narrative? simplywall.st Sun, 07 Jun 2026 21:18:30 GMT
• how investors may respond to rhythm pharmaceuticals (rytm) updating its bardet-biedl diagnosis algorithm Yahoo Finance Sun, 07 Jun 2026 07:00:00 GMT
• rhythm pharmaceuticals, inc. revenue breakdown – xetr:1rv TradingView Sat, 06 Jun 2026 19:28:46 GMT
• assessing rhythm pharmaceuticals (rytm) valuation as rare disease growth story faces high sales multiple simplywall.st Fri, 05 Jun 2026 07:00:00 GMT
• rhythm pharmaceuticals stock rating reaffirmed by citizens Investing.com UK Thu, 04 Jun 2026 09:16:42 GMT
• rhythm pharmaceuticals (rytm) jefferies global healthcare conference 2026 summary Quartr Thu, 04 Jun 2026 07:00:00 GMT
• rhythm pharmaceuticals advances as a rare disease leader with fda-approved imcivree for obesity. Pluang Wed, 03 Jun 2026 08:34:27 GMT
• Rhythm Pharmaceuticals: The Rare Obesity Platform Is Becoming A Commercial Engine Seeking Alpha Wed, 03 Jun 2026 07:00:00 GMT
• rhythm pharmaceuticals stock rating reaffirmed by citizens Investing.com Wed, 03 Jun 2026 07:00:00 GMT
• analysts estimate rhythm pharmaceuticals, inc. (rytm) to report a decline in earnings: what to look out for Eastern Progress Tue, 02 Jun 2026 23:14:12 GMT
• rhythm pharmaceuticals, inc. (rytm): investor outlook reveals 56% potential upside amid robust revenue growth DirectorsTalk Interviews Mon, 01 Jun 2026 09:23:54 GMT
• rytm financials: revenue breakdown, margins & competitor comparison Intellectia AI Mon, 01 Jun 2026 06:27:03 GMT
• could a new bardet-biedl diagnostic algorithm subtly reshape rhythm pharmaceuticals’ (rytm) rare-disease reach? simplywall.st Sun, 31 May 2026 04:23:01 GMT
• rhythm algorithm aims to clarify bardet biedl diagnosis and market potential simplywall.st Sat, 30 May 2026 07:00:00 GMT
• what does the fda's pdufa extension signal for rhythm pharmaceuticals Kavout Fri, 29 May 2026 23:55:56 GMT
• Rhythm Pharmaceuticals Announces Seven Abstracts Accepted for Presentation at ENDO 2026 Yahoo Finance Fri, 29 May 2026 07:00:00 GMT
• inside rhythm’s seven endo 2026 talks on hypothalamic obesity, pws, bbs Stock Titan Fri, 29 May 2026 07:00:00 GMT
• rhythm pharmaceuticals to present seven abstracts at endo 2026, highlighting advances in treatment for rare neuroendocrine disease... Quiver Quantitative Fri, 29 May 2026 07:00:00 GMT
• new bardet-biedl diagnostic guide tackles years-long diagnosis delays Stock Titan Thu, 28 May 2026 07:00:00 GMT
• breakeven on the horizon for rhythm pharmaceuticals, inc. (nasdaq:rytm) Moomoo Thu, 28 May 2026 07:00:00 GMT
• (rytm) movement as an input in quant signal sets Stock Traders Daily Tue, 26 May 2026 15:00:01 GMT
• rhythm pharmaceuticals announces participation in upcoming investor conferences Yahoo Finance Tue, 26 May 2026 07:00:00 GMT
• biopharma ceo and cfo to join investor fireside chats at june events Stock Titan Tue, 26 May 2026 07:00:00 GMT
• rhythm pharmaceuticals to present at major healthcare conferences in june 2026 Pluang Tue, 26 May 2026 07:00:00 GMT
• rhythm pharmaceuticals, inc. (rytm) stock analysis: exploring a 57% upside potential in the biotech sector DirectorsTalk Interviews Mon, 25 May 2026 07:00:00 GMT
• is rhythm pharmaceuticals poised for a breakthrough in hypothalamic obesity Kavout Thu, 21 May 2026 15:49:17 GMT
• bofa securities maintains rhythm pharmaceuticals(rytm.us) with buy rating, announces target price $149 富途牛牛 Wed, 20 May 2026 17:15:08 GMT
• [form 4] rhythm pharmaceuticals, inc. insider trading activity Stock Titan Wed, 20 May 2026 07:00:00 GMT
• rhythm pharmaceuticals signals momentum despite rising costs TipRanks Wed, 20 May 2026 06:35:54 GMT
• rhythm pharmaceuticals cao christopher german sells $428,131 in stock by investing.com Investing.com South Africa Wed, 20 May 2026 02:34:07 GMT
• rhythm pharmaceuticals (rytm) officer sells 4,643 shares after exercising options Stock Titan Tue, 19 May 2026 07:00:00 GMT
• rhythm pharmaceuticals cao christopher german sells $428,131 in stock Investing.com Tue, 19 May 2026 07:00:00 GMT
• top rhythm pharmaceuticals executive makes major insider stock move TipRanks Tue, 19 May 2026 07:00:00 GMT
• rhythm pharmaceuticals, inc. (rytm) reports q1 loss, tops revenue estimates MSN Tue, 19 May 2026 05:24:42 GMT
• rhythm grabs a new obesity approval; how it edged in where lilly, novo have fallen flat MSN Tue, 19 May 2026 02:32:44 GMT
Rhythm Pharmaceuticals, Inc(NASDAQ:RYTM)
Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of rare genetic diseases of obesity. The company's lead product candidate is IMCIVREE, a potent melanocortin-4 receptor for the treatment of ...
Website: http://www.rhythmtx.com
Founded: 2008
Full Time Employees: 70
Sector: Healthcare
Industry: Biotechnology
